Genexine, Top Search Ranking... Stock Price Up 0.28%
Genexine has ranked among the top searched stocks for 13 days in the past month.
As of 1:31 PM on the 1st, Genexine is trading at 180,300 KRW, up 0.28% from the previous day. This marks a 52.8% increase compared to August 12. Genexine is known as a specialized company in biopharmaceutical development.
Today, foreigners have net sold 12,000 shares of Genexine, and institutions have net sold 3,000 shares, according to provisional data. Over the past five days, individual investors have net bought 421,534 shares, while foreigners and institutions have net sold 18,931 shares and 144,152 shares, respectively.
On August 31, Genexine became a market issue with the news of 'FDA approval for Kimria combination therapy Phase 1b clinical trial,' leading to a rise in its stock price.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Looks Even More Like Him in Person": Albino Water Buffalo with Golden Hair and Pink Skin Nicknamed 'Trump'
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
